Interviews

Jeffrey Fudin, PharmD, DAAPM, FCCP, FASHP, discusses whether or not allowing pharmacists to dispense naloxone without a prescription can help reduce fatal outcomes.

Theodore Pikoulas, PharmD, BCPP, the Associate Director of Behavioral Health Pharmacy Programs for Community Care of North Carolina, discusses how pharmacists can combat the stigmas associated with mental illness.

Michael Cawley, BS, PharmD, RRT, CPFT, FCCM, professor of clinical pharmacy at the University of the Sciences, discusses what therapeutic options are available for managing asthma and chronic obstructive pulmonary disorder.

Sneha Srivastava, PharmD, BCACP, describes the role of the pharmacist at the time of discharge for heart failure patients.

Theodore Pikoulas, PharmD, BCPP, the Associate Director of Behavioral Health Pharmacy Programs for Community Care of North Carolina, discusses how pharmacists can promote behavioral health in their daily practice.

Dan Benamoz, RPh, President and CEO of Pharmacy Development Services, discusses how independent pharmacists can improve their bottom line.

Seena Haines, PharmD, BCACP, FAPhA, FASHP, BC-ADM, CDE, professor and department chair for Pharmacy Practice, University of Mississippi School of Pharmacy, outlines some risk factors for obesity.

Susan Cornell, PharmD, CDE, FAPhA, FAADE, describes the risks for ketoacidosis and serious urinary tract infection associated with use of SGLT2 inhibitors.

Jeffrey Fudin, PharmD, DAAPM, FCCP, FASHP, outlines his pros and cons for expanded access to naloxone.

Theodore Pikoulas, PharmD, BCPP, the Associate Director of Behavioral Health Pharmacy Programs for Community Care of North Carolina, discusses the roles that pharmacists can play on interdisciplinary health care teams.

Jon Roth, CEO of the California Pharmacists Association, explains how pharmacists can help prepare their patients for natural disasters.

Julie A. Dopheide, PharmD, BCPP, FASHP, professor of clinical pharmacy, psychiatry, and behavioral sciences at the University of Southern California School of Pharmacy, lists off pharmacologic treatment options for patients with insomnia.

Susan Cornell, PharmD, CDE, FAPhA, FAADE, discusses the contraindications and adverse effects pharmacists should consider when recommending antidiabetic agents.

Jennifer Costello, PharmD, BCPS, BC-ADM, discusses several new and emerging therapies for type 2 diabetes and glycemic control.

Cheryl Viracola, RPh, PharmD, the Network Pharmacy Programs Manager for Community Care of Wake and Johnston Counties, discusses the challenges of improving naloxone access.

Jeffrey Goad, PharmD, MPH, FAPhA, offers advice for pharmacists looking to bolster their immunization and travel health programs.

Cheryl Viracola, RPh, PharmD, the Network Pharmacy Programs Manager for Community Care of Wake and Johnston Counties, discusses the benefits of expanded naloxone access.

Dennis Williams, PharmD, FAPhA, discusses how pharmacists can help implement trigger control strategies to help prevent allergic rhinitis.

Jeffrey Goad, PharmD, MPH, FAPhA, discusses vaccine recommendations for special populations including pregnant women and health care professionals.

Jeffrey Goad, PharmD, MPH, FAPhA, discusses vaccine recommendations for immunocompromised patients.

Dennis Williams, PharmD, FAPhA, discusses the signs and symptoms of allergic rhinitis and how pharmacists can differentiate them from those of the common cold.

Susan Cornell, PharmD, CDE, FAPhA, FAADE forecasts the future landscape for antidiabetic agents recommended as a second-line treatment for type 2 diabetics.

Jon Roth, CEO of the California Pharmacists Association, discusses the protocol for pharmacists when they are dispensing birth control.

Jon Roth, CEO of the California Pharmacists Association, discusses the successes and challenges California pharmacists have faced in dispensing naloxone.

Susan Cornell, PharmD, CDE, FAPhA, FAADE discusses the patient counseling points pharmacists should be aware of for antidiabetic agents.

Susan Cornell, PharmD, CDE, FAPhA, FAADE outlines the classes of antidiabetic agents recommended as a second-line treatment for type 2 diabetics.

Jeffrey Goad, PharmD, MPH, FAPhA, discusses some promising new vaccines that are currently in the development pipeline.

Jon Roth, CEO of the California Pharmacists Association, discusses the status of birth control prescribing among pharmacists in California.

Seena Haines, PharmD, BCACP, FAPhA, FASHP, BC-ADM, CDE, professor and department chair for Pharmacy Practice, University of Mississippi School of Pharmacy, outlines 3 components all weight-loss counseling strategies should include.

Seena Haines, PharmD, BCACP, FAPhA, FASHP, BC-ADM, CDE, professor and department chair for Pharmacy Practice, University of Mississippi School of Pharmacy, discusses mistakes that patients often make that can impede on their ability to achieve their weight loss goals.